We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Udg Healthcare Public Limited Company | LSE:UDG | London | Ordinary Share | IE0033024807 | ORD EUR0.05 (CDI) |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 1,079.00 | 1,078.00 | 1,079.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From May 2019 to May 2024
TIDMUDG
RNS Number : 8453K
UDG Healthcare Public Limited Co.
27 September 2016
UDG HEALTHCARE PLC
CAPITAL MARKETS EVENT
27 September 2016: UDG Healthcare plc ("the Group"), a leading international provider of healthcare services, will host a Capital Markets Event for investors and analysts this afternoon in London.
The event will be hosted by CEO Brendan McAtamney, with presentations from the UDG Healthcare executive and divisional management teams. The event will provide attendees with an overview of the Group, including an update on strategy and Group development.
UDG Healthcare issued its Q3 update on 4 August 2016, for the period from 1 April 2016 to 30 June 2016 and no further financial or trading update will be provided today.
Copies of the presentations will be available after the event at www.udghealthcare.com. A recording of the presentations will be made available in due course.
ENDS
For reference:
Hot Features
Premium
Investors and Analysts:
Alan Ralph Keith Byrne
CFO Head of Investor Relations,
Strategy & Corporate
Communications
UDG Healthcare plc UDG Healthcare plc
Tel: +353-1-468-9000 Tel: +353-1-468-9000
Media:
Lisa Kavanagh / Nick Dibden / Jack Hickey
Powerscourt
Tel: +44-207-250-1446
About UDG Healthcare plc:
UDG Healthcare plc (LON: UDG) is a leading international partner of choice delivering clinical, commercial, communication and packaging services to the healthcare industry, employing over 7,000 employees at operations across 20 countries including the US, UK, Ireland and Germany.
UDG Healthcare plc operates across three divisions: Ashfield Commercial & Medical Services, Sharp Packaging Services and Aquilant Specialist Healthcare Services.
Ashfield Commercial & Medical Services is a global leader in commercialisation services for the pharmaceutical and healthcare industry, operating across two broad areas of activity: commercial and clinical services, and healthcare communications. It focuses on supporting healthcare professionals and patients at all stages of the product life cycle. The division provides sales teams, healthcare communications, telesales, nurse educators, medical information, pharmacovigilance (drug safety), regulatory and event management services to over 300 healthcare companies in 18 countries.
Sharp Packaging Services is a global leader in contract packaging and clinical trial packaging services for the pharmaceutical and biotechnology industries, operating from state of the art facilities across the US and Europe. Sharp is also a world leader in 'Track and Trace' serialisation services, which will require all prescription drugs to have a unique serial code for authentication and traceability.
Aquilant Specialist Healthcare Services is a leading provider of outsourced sales, marketing, distribution and engineering services to the medical and scientific sectors in the UK, Ireland and the Netherlands.
The company is listed on the London Stock Exchange and is a constituent of the FTSE 250.
For more information, please go to: www.udghealthcare.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCEADNKALKKEFF
(END) Dow Jones Newswires
September 27, 2016 02:00 ET (06:00 GMT)
1 Year Udg Healthcare Public Chart |
1 Month Udg Healthcare Public Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
